INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME

The present invention relates to compounds which are inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for the treatment of non-insulin dependent type 2 diabetes,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DINGES, JURGEN, SHUAI, QI, WINN, MARTIN, PATEL, JYOTI R, YONG, HONG, YEH, VINCE S, ROHDE, JEFFREY J, SORENSEN, BRYAN K, LINK, JAMES T
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to compounds which are inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for the treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome and other diseases and conditions that are mediated by excessive glucocorticoid action. La présente invention concerne des composés inhibiteurs de l'enzyme 11-bêta-hydroxystéroïde déshydrogénase de Type 1. La présente invention concerne en outre l'emploi d'inhibiteurs de l'enzyme 11-bêta-hydroxystéroïde déshydrogénase de Type 1 dans le traitement du diabète de type 2 non insulinodépendant, de l'insulinorésistance, de l'obésité, des troubles lipidiques, du syndrome métabolique et d'autres maladies et états pathologiques médiés par une suractivité des glucocorticoïdes.